Detection of Multidrug-Resistant Enterobacterales-From ESBLs to Carbapenemases

被引:41
|
作者
Noster, Janina [1 ]
Thelen, Philipp [1 ,2 ]
Hamprecht, Axel [1 ,2 ,3 ,4 ]
机构
[1] Carl von Ossietzky Univ Oldenburg, Dept Med Microbiol & Virol, D-26129 Oldenburg, Germany
[2] Klinikum Oldenburg, Inst Med Microbiol & Virol, D-26133 Oldenburg, Germany
[3] Univ Cologne, Univ Hosp, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany
[4] German Ctr Infect Res, Partner Site Bonn Cologne, D-50937 Cologne, Germany
来源
ANTIBIOTICS-BASEL | 2021年 / 10卷 / 09期
关键词
multidrug resistance; preanalytical parameters; detection methods; ESBL; carbapenemase; CPE; SPECTRUM-BETA-LACTAMASE; DESORPTION IONIZATION-TIME; RAPIDEC(R) CARBA NP; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; MALDI-TOF; ANTIMICROBIAL RESISTANCE; PHENOTYPIC DETECTION; LABORATORY DETECTION; CHROMOGENIC MEDIUM;
D O I
10.3390/antibiotics10091140
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Multidrug-resistant Enterobacterales (MDRE) are an emerging threat to global health, leading to rising health care costs, morbidity and mortality. Multidrug-resistance is commonly caused by different beta-lactamases (e.g., ESBLs and carbapenemases), sometimes in combination with other resistance mechanisms (e.g., porin loss, efflux). The continuous spread of MDRE among patients in hospital settings and the healthy population require adjustments in healthcare management and routine diagnostics. Rapid and reliable detection of MDRE infections as well as gastrointestinal colonization is key to guide therapy and infection control measures. However, proper implementation of these strategies requires diagnostic methods with short time-to-result, high sensitivity and specificity. Therefore, research on new techniques and improvement of already established protocols is inevitable. In this review, current methods for detection of MDRE are summarized with focus on culture based and molecular techniques, which are useful for the clinical microbiology laboratory.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Multidrug-resistant tuberculosis
    Dheda, Keertan
    Mirzayev, Fuad
    Cirillo, Daniela Maria
    Udwadia, Zarir
    Dooley, Kelly E.
    Chang, Kwok-Chiu
    Omar, Shaheed Vally
    Reuter, Anja
    Perumal, Tahlia
    Horsburgh, C. Robert
    Murray, Megan
    Lange, Christoph
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01)
  • [42] Multidrug-resistant tuberculosis
    Zager, Ellen M.
    McNerney, Ruth
    BMC INFECTIOUS DISEASES, 2008, 8 (1)
  • [43] Multidrug-resistant tuberculosis
    Albino, JA
    Reichman, LB
    CURRENT OPINION IN INFECTIOUS DISEASES, 1997, 10 (02) : 116 - 122
  • [44] Multidrug-Resistant Fungi
    de Moraes, Daniel Clemente
    Ferreira-Pereira, Antonio
    JOURNAL OF FUNGI, 2024, 10 (10)
  • [45] MULTIDRUG-RESISTANT TUBERCULOSIS
    GALAI, N
    GRAHAM, N
    CHAISSON, R
    NELSON, KE
    VLAHOV, D
    LEWIS, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16): : 1172 - 1173
  • [46] Multidrug-resistant tuberculosis
    Moreira Lemos, Antonio Carlos
    Matos, Eliana Dias
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (02): : 239 - 246
  • [47] Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers
    Edgar I. Campos-Madueno
    Melika Moradi
    Yasmine Eddoubaji
    Fatemeh Shahi
    Sina Moradi
    Odette J. Bernasconi
    Aline I. Moser
    Andrea Endimiani
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 229 - 254
  • [48] Multidrug-Resistant Enterobacterales in Community-Acquired Urinary Tract Infections in Djibouti, Republic of Djibouti
    Mohamed, Hasna Said
    Aboubaker, Mohamed Houmed
    Dumont, Yann
    Didelot, Marie-Noelle
    Michon, Anne-Laure
    Galal, Lokman
    Jean-Pierre, Helene
    Godreuil, Sylvain
    ANTIBIOTICS-BASEL, 2022, 11 (12):
  • [50] MULTIDRUG-RESISTANT TUBERCULOSIS
    DOOLEY, SW
    JARVIS, WR
    MARTONE, WJ
    SNIDER, DE
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) : 257 - 259